Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke

MLA

Alexander Kleinknecht, et al. “Bridging-Therapy with Intravenous Recombinant Tissue Plasminogen Activator Improves Functional Outcome in Patients with Endovascular Treatment in Acute Stroke.” Journal of the Neurological Sciences, vol. 372, Jan. 2017, pp. 300–04. EBSCOhost, https://doi.org/10.1016/j.jns.2016.12.001.

APA

Alexander Kleinknecht, Marios Psychogios, Jan Liman, Katrin Wasser, Marlena Schnieder, Ilko Maier, Michael Knauth, Mathias Bähr, Katharina Schregel, Daniel Behme, & Ioannis Tsogkas. (2017). Bridging-therapy with intravenous recombinant tissue plasminogen activator improves functional outcome in patients with endovascular treatment in acute stroke. Journal of the Neurological Sciences, 372, 300–304. https://doi.org/10.1016/j.jns.2016.12.001

Chicago

Alexander Kleinknecht, Marios Psychogios, Jan Liman, Katrin Wasser, Marlena Schnieder, Ilko Maier, Michael Knauth, et al. 2017. “Bridging-Therapy with Intravenous Recombinant Tissue Plasminogen Activator Improves Functional Outcome in Patients with Endovascular Treatment in Acute Stroke.” Journal of the Neurological Sciences 372 (January): 300–304. doi:10.1016/j.jns.2016.12.001.